Top 50 Companies in Cardiac Biomarkers Market in The World in 2025: Market Research Report (2024-2035)
RELEASE DATE: Aug 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Cardiac Biomarkers Market Size is Projected To Grow from USD 21.01 Billion in 2024 to USD 81.01 Billion by 2035, at a CAGR of 14.45 % during the forecast period 2025–2035. Future opportunities lie in point-of-care testing, AI-driven diagnostics, and personalized medicine integration, enabling faster detection, improved clinical decisions, and expanding adoption in emerging markets with rising cardiovascular disease prevalence.
Introduction
The Cardiac Biomarkers Market refers to diagnostic tests that measure biological markers released into the blood during heart-related conditions such as myocardial infarction, heart failure, and acute coronary syndrome. These biomarkers, including troponins, CK-MB, and BNP, play a vital role in early disease detection, risk stratification, and treatment monitoring. Market growth is driven by the rising global burden of cardiovascular diseases, growing demand for rapid diagnostic solutions, and advancements in biomarker assay technologies. Additionally, increasing healthcare expenditure, supportive government initiatives, and the integration of biomarkers with point-of-care testing are further strengthening market expansion and clinical adoption worldwide.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights - Download The Brochure Now and dive deeper into the future of the Cardiac Biomarkers market.
Cardiac Biomarkers Market Size & Statistics
- The Market Size for Cardiac Biomarkers Was Estimated to be Worth USD 21.01 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 14.45 % Between 2025 and 2035.
- The Global Cardiac Biomarkers Market Size is Anticipated to Reach USD 81.01 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Cardiac Biomarkers Market.
- Asia Pacific is expected To Grow the fastest during the forecast period in the Cardiac Biomarkers Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Cardiac Biomarkers market. The increase can be linked to the rising affordability of advanced cardiac diagnostics, the modernization of countries, and the growth in disposable income. The growing incidence of cardiovascular diseases (CVDs) in this area has elevated the need for advanced diagnostics, government backing for disease-targeted research, and healthcare spending. India experiences a higher prevalence of cardiovascular diseases compared to other developing nations. Consequently, these elements are driving the worldwide cardiac biomarkers market.
North America is expected to generate the highest demand during the forecast period in the Cardiac Biomarkers market. The development of healthcare infrastructure and the widespread use of cardiac biomarkers for diagnostic and prognostic evaluation have contributed to regional growth. The growing senior demographic necessitates biomarker evaluations to identify conditions such as acute myocardial infarction, which boosts the need for testing products. This rise in cardiovascular disease risk places further strain on healthcare systems, resulting in heightened demand for the cardiac biomarkers sector. Major key players are present in North America’s cardiac biomarkers market. These elements are driving the expansion of the cardiac biomarkers market in North America.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Cardiac Biomarkers market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 5 Cardiac Monitoring Startups Impacting the Healthcare Industry
1. FibriCheck – Heart Rhythm Monitoring
Atrial fibrillation is a common heart rhythm disorder that raises the risk of stroke, heart failure, and other cardiovascular complications, often without noticeable symptoms. Early detection is therefore crucial. Smartphone-based apps provide a convenient way to monitor heart rhythms from home. FibriCheck, a Belgian startup, offers a CE-certified Class IIa diagnostic app for detecting arrhythmias, including atrial fibrillation. The app is user-friendly and delivers results within a minute by simply placing a finger on the smartphone. These results can be securely shared with doctors for further analysis, making it an effective remote monitoring tool.
2. Cardiolyse – Cloud Analytics Platform
With the growing use of wearables and connected devices, vast amounts of heart health data are generated daily. Advanced analytics platforms are essential to process this data for timely interventions. Cardiolyse, a UK-based startup, has developed a CE-marked cloud analytics platform for real-time remote monitoring and preventive care. It analyzes electrocardiogram (ECG) and heart rate variability (HRV) data to provide actionable insights. Uniquely, the platform can forecast potential cardiac events up to two months in advance, empowering clinicians to intervene earlier and improve patient outcomes through predictive, data-driven care.
3. VivaLNK – Wearable Patch
Cardiovascular diseases remain one of the leading global health concerns, driving the demand for continuous monitoring solutions. VivaLNK, a US-based startup, offers a reusable and rechargeable wearable patch designed for long-term cardiac monitoring. The lightweight, water-resistant device tracks heart rate, ECG, respiratory rate, and physical motion, while also enabling retrospective data analysis. At just 7.5 grams, the patch is comfortable for daily use. Importantly, VivaLNK’s solution holds CE certification and FDA clearance, ensuring reliability and clinical-grade performance for continuous, real-world cardiac monitoring.
4. Hulu Devices – Auscultatory Blood Pressure Measurement
The auscultatory method remains the gold standard for non-invasive blood pressure monitoring. Modern smartphone-based solutions are making this technique more accessible and practical. Hulu Devices, a China-based startup, has developed Accutension, a kit comprising a cuff and companion mobile app. The app records Korotkoff sounds—critical for blood pressure measurement—and stores them for later validation. This eliminates the need for real-time listening, while features such as sound playback, visualization, and deflation rate display enhance diagnostic accuracy. The solution simplifies blood pressure monitoring and enables easier data sharing with healthcare professionals.
5. Bold Diagnostics – Finger Monitor
Hypertension, often termed the “silent killer,” remains a major risk factor for cardiovascular disease and stroke, frequently going undetected due to its asymptomatic nature. Bold Diagnostics, a US-based startup, addresses this challenge with its cuffless finger monitor, Bold CTRL. The device requires only a few heartbeats to provide accurate blood pressure readings, enabling quick and convenient monitoring at home. Paired with the Bold mobile app, users can track long-term health trends and generate personalized reports. These can be shared directly with physicians, improving patient engagement and early intervention in hypertension management.
Top 16 Companies Leading the Cardiac Biomarkers Market
- Roche Diagnostics Corporation
- Thermo Fisher Scientific
- Randox laboratories
- Beckman Coulter
- Siemens Healthcare
- Ortho Clinical Diagnostics
- Trinity Biotech
- Meso Scale Diagnostics
- Abbott laboratories
- BioMerieux
- Becton
- Dickinson and Co.
- Luminex Corporation
- Bio-Rad Laboratories
- Alere Inc.
- Others
1. Roche Diagnostics Corporation
Headquartered in Basel, Switzerland
Roche Diagnostics is a global leader in in-vitro diagnostics and a key player in the cardiac biomarkers market. The company’s advanced assays, such as troponin and NT-proBNP tests, are widely used in hospitals and laboratories for rapid diagnosis of acute coronary syndromes and heart failure. Roche continuously invests in R&D to enhance point-of-care testing solutions, enabling faster clinical decision-making. Its integrated platforms and automated systems improve efficiency in cardiovascular diagnostics, making Roche one of the most trusted providers in this domain. Strategic partnerships and global presence further strengthen its leadership in cardiac biomarker testing.
2. Thermo Fisher Scientific
Headquartered in Waltham, Massachusetts, USA
Thermo Fisher Scientific is a leading life sciences company with a strong footprint in cardiac biomarker research and diagnostics. The company provides high-sensitivity immunoassays, clinical chemistry analyzers, and reagents for detecting biomarkers like troponin, myoglobin, and CK-MB. Through its wide portfolio, Thermo Fisher supports hospitals and laboratories in accurate diagnosis of myocardial infarction and related conditions. It also collaborates with pharmaceutical companies to develop companion diagnostics for cardiovascular drugs. With its emphasis on innovation, scalability, and global distribution, Thermo Fisher plays a crucial role in advancing cardiac biomarker testing and improving patient outcomes.
3. Randox Laboratories
Headquartered in Crumlin, Northern Ireland, UK
Randox Laboratories is a diagnostics company specializing in innovative biomarker testing, including cardiovascular diagnostics. Randox offers a wide range of cardiac biomarker assays for early detection and risk assessment of heart disease, including troponin, CK-MB, and NT-proBNP tests. Its patented Biochip Array Technology enables multiplex testing, providing comprehensive cardiovascular profiles from a single sample. Randox also develops point-of-care devices for emergency and routine use, improving clinical efficiency. By integrating advanced diagnostics with preventive healthcare solutions, Randox has positioned itself as a significant contributor to cardiac biomarker innovations across hospitals, labs, and research institutions globally.
4. Beckman Coulter
Headquartered in Brea, California, USA
A subsidiary of Danaher Corporation and, Beckman Coulter is a leader in clinical diagnostics and laboratory automation, including cardiac biomarkers testing. The company’s immunoassay systems deliver fast, high-sensitivity troponin and BNP results, critical for emergency and hospital settings. Beckman Coulter focuses on delivering cost-effective and scalable solutions for laboratories worldwide. Its strong expertise in laboratory automation enhances efficiency in cardiac diagnostics by reducing turnaround time. Through ongoing product innovation and integration of AI-driven solutions, Beckman Coulter is strengthening its role in improving cardiovascular disease diagnosis and treatment pathways across healthcare systems globally.
5. Siemens Healthcare
Headquartered in Erlangen, Germany
Siemens Healthcare (Siemens Healthineers) is a global pioneer in medical technology and diagnostics, with a strong presence in the cardiac biomarkers market. The company offers advanced immunoassay systems and high-sensitivity cardiac troponin tests that support rapid and accurate diagnosis of myocardial infarction and heart failure. Siemens Healthineers also provides fully automated laboratory solutions, integrating biomarkers with imaging and digital platforms to improve cardiovascular care. Its focus on innovation, including AI-powered diagnostics and point-of-care testing, ensures reliable results in both emergency and clinical settings. With a robust global network, Siemens plays a vital role in cardiac diagnostics advancement.
Are you ready to discover more about the Cardiac Biomarkers market?
The report provides an in-depth analysis of the leading companies operating in the global Cardiac Biomarkers market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Roche Diagnostics Corporation.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Thermo Fisher Scientific
- Randox laboratories
- Beckman Coulter
- Siemens Healthcare
- Ortho Clinical Diagnostics
- Trinity Biotech
- Meso Scale Diagnostics
- Abbott Laboratories
- BioMerieux
Conclusion
The global cardiac biomarkers market is poised for strong growth, fueled by the increasing prevalence of cardiovascular diseases, technological advancements in diagnostic assays, and the growing adoption of point-of-care testing. With innovation in AI-driven solutions and personalized medicine, the industry is rapidly evolving to deliver faster, more accurate, and patient-centric diagnostics. Regional dynamics, including strong demand in North America and rapid growth in Asia Pacific, highlight the global potential of this sector. Supported by government initiatives, rising healthcare spending, and robust competition among leading players, the cardiac biomarkers market offers vast opportunities for future expansion.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?